A new study shows that a 70-year-old malaria drug can block immune cells in the liver so nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of targeted drug delivery, according to a team of researchers led by Houston Methodist.
Many cancer patients do not respond to chemotherapies because the drugs never reach the cancer cells. Even in nanomedicine, which is one of the best new methods for delivering drugs to a tumor, only about one percent of a dose of nanoparticles will successfully arrive at the intended tumor site, while the rest are filtered out by the immune cells of the liver and spleen.
Using chloroquine, the researchers not only increased the circulation of nanoparticles in the body, but also reduced the body’s filtration of nanoparticles, as well as improved drug delivery to breast tumors. The study was recently published in Scientific Reports, a research journal from the Nature Publishing Group.
Led by Mauro Ferrari, Ph.D., president and CEO of the Houston Methodist Research Institute, and Joy Wolfram, Ph.D. (now at Mayo Clinic’s campus in Jacksonville, Florida), the research showed that chloroquine interfered with immune cells called macrophages, which are used by the body to identify microscopic foreign objects and destroy them.
In this study, mice models received injections of chloroquine, followed by an injection of nanoparticles. Chloroquine decreased the macrophages’ ability to clean up the nanoparticles. The findings are significant, because the nanoparticles not only remained in circulation, but also accumulated in mouse tumors, as well as in the lungs of healthy mice, suggesting that the approach also may enhance treatment for lung diseases.
Chloroquine was invented in the 1940s for the prevention and treatment of malaria. Since it mildly suppresses the immune system, the drug also is used in some autoimmune disorders, such as rheumatoid arthritis and lupus. Apart from this research, the drug is also being studied in other cancers, such as triple-negative breast cancer and pancreatic cancer.
Ferrari, considered one of the founders of nanomedicine and transport oncophysics (the physics of mass transport within a cancer lesion), says researchers and clinicians need to understand the limitations of transport mechanisms to identify effective immunotherapy treatments for patients.
The Latest on: Drug delivery
- Pulmonary Drug Delivery Devices/Systems Market Insights into the Competitive Scenario of the Market 2025 on October 8, 2018 at 12:47 pm
Pulmonary drug delivery devices or systems includes devices for delivering drugs through medical devices such as inhalers and nebulizers in patients with respiratory illnesses such as asthma. The devi... […]
- Inhalation Drug Delivery: Considerations for Toxicology and Pharmacology Research, New Webinar Hosted by Xtalks on October 8, 2018 at 5:25 am
TORONTO, October 8, 2018 (Newswire.com) - Drug delivery to the lungs in both the clinical and non-clinical setting is a unique combination of formulation, delivery device and the system/model that the ... […]
- UT researchers discover how to control nanomotors, could improve drug delivery on October 7, 2018 at 11:15 pm
Tiny devices driven by light could change the biomedical world. UT scientists recently discovered that light can be used to select the motion of nanomotors, micro-devices that are promising in ... […]
- A Caterpillar Robot for Drug Delivery? Ya, That's a Thing on October 5, 2018 at 10:55 am
Drug delivery is a significant part of medical research since a drug cannot work if it cannot access the part of the body where it's needed. Nanotechnology, including quantum dots and miniature roboti... […]
- Topical Drug Delivery Market Forecast 2017 - 2025 : Janssen Global Services, LLC, Galderma S.A., and 3M Drug Delivery Systems on October 4, 2018 at 4:49 am
Topical drugs delivery includes treatment of body surface such as outer membrane or skin. The drugs are in the form of solid, semi-solid, liquid, gel, and transdermal patches. Topical drugs such as as... […]
- Pulmonary Drug Delivery Market worth 52.37 Billion USD by 2021 according to new research report on October 3, 2018 at 5:37 pm
According to the new market research report "Pulmonary Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain ... […]
- New computer model designs a drug delivery strategy to fight cancer on October 3, 2018 at 1:35 pm
A better understanding of how nanoparticles move from the bloodstream into a tumor could eventually lead to more effective cancer treatment. Stanford researchers have created a computer simulation, va... […]
- Medherant wins grant to support manufacturing program for transdermal drug-delivery patches on October 3, 2018 at 7:19 am
Medherant said today that it was awarded a Medicines Manufacturing Grant from Innovate UK to support the manufacturing of transdermal drug-delivery patches. The company plans to expand its pilot-scale ... […]
- Global Drug Delivery Devices Market Set to Grow at a Healthy CAGR during 2018-2025 on October 3, 2018 at 2:08 am
Global Drug Delivery Devices Market 2018-2025: The global drug delivery devices market has advanced over the six decades; initially pills were emphasized on, but in the last twelve years, drugs delive... […]
- Sperm-inspired robots could be the next big thing in drug delivery on October 2, 2018 at 2:49 pm
Scientists in the United Kingdom have turned to the humble human sperm in their quest to design the ultimate swimming robot. Made of a tiny magnetic head and squiggly elastic tail, the flea-size drone... […]
via Google News and Bing News